4
Changes in Ownership
C4 Therapeutics, Inc. Filed Acc 0001209191-21-045691
Chief Medical Officer sold 15,000 shares at an average $37.98 ($569,666)
- Chief Medical Officer acquired 15,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Crystal Adam Chief Medical Officer | 2021-07-01 | Option exercise | +15,000 | $6.50 | $97,500 | 15,000 | D |
| Crystal Adam Chief Medical Officer | 2021-07-01 | Sale | −13,300 | $37.93 | $504,420 | 1,700 | D |
| Crystal Adam Chief Medical Officer | 2021-07-01 | Sale | −1,700 | $38.38 | $65,246 | 0 | D |
| Derivatives | |||||||
| Crystal Adam Chief Medical Officer | 2021-07-01 | Option exercise · Stock Option (Right to Buy) | −15,000 | 142,292 | D | ||
| Open-market sales · 15,000 sh · avg $37.98 · $569,666 | |||||||
Loading xslF345X03/doc4.xml…